Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B8f6f1aef6b4a5aafffe7495312dd21fd> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B8f6f1aef6b4a5aafffe7495312dd21fd NCIT_P378 "NCI" @default.
- B8f6f1aef6b4a5aafffe7495312dd21fd type Axiom @default.
- B8f6f1aef6b4a5aafffe7495312dd21fd annotatedProperty IAO_0000115 @default.
- B8f6f1aef6b4a5aafffe7495312dd21fd annotatedSource NCIT_C104008 @default.
- B8f6f1aef6b4a5aafffe7495312dd21fd annotatedTarget "An orally bioavailable inhibitor of both phosphoinositide 3-kinase (PI3K) class I and pan histone deacetylase (HDAC) enzymes, with potential antineoplastic activity. Upon oral administration, fimepinostat inhibits the activity of both PI3K class I isoforms and HDAC, thereby preventing the activation of the PI3K-AKT-mTOR signal transduction pathway that is often overactivated in many cancer cell types. This may prevent growth of PI3K and/or HDAC-expressing tumor cells. CUDC-907 shows an increased inhibition of tumor cell growth and induction of apoptosis when compared to inhibitors that target either PI3K or HDAC." @default.